STRONG and VITAL No 5

The weapons of cancer medicine have remained unchan ged for half a century: scalpel, radiation, and toxic drugs—slightly modified in recent years by toxic gene products. Nothing will change as long as the “valid” narrative is maintained: Cancer is a genetic disease. Alternative approaches are no match for the concentrated financial power of the pharmaceutical industry and the acade mic medicine associated with it. Gerson and Burzynski, for example, can hardly be found in the scientific literature; Wiki pedia characterizes them as quacks. The Gerson Clinic is in Mexico because it did not receive a license in the USA. The Burzynski Clinic is in Texas but is in ongoing dispute with the FDA (Food and Drug Administration). Tom Seyfried is

ply, is drugs against cancer. Cancer is the second most common cause of death, and cancer drugs gene rate as much revenue as the treat ment of cardiovascular diseases (the most common cause of death). Diabetes and rheumatic diseases (including immune diseases) together: by 2026, the market for cancer drugs will be as large as that for all other drug groups together (Statista). There seems to be no upper limit to pricing, with five-figure costs for a treatment cycle soon becoming the norm. No wonder that the cause of most personal bankruptcies in the USA is “healthcare costs,” or rather: doctor and hospital bills. In Germany, gene therapy treat ment can cost up to 4.2 million euros (notification from the Technical Health Insurance Fund dated 24 July 2024). Cancer Is the Manna of the Pharmaceutical Industry And the benefit for the patient? For all common cancers, vanishingly small. However, there are still no statistics on how many patients have died from cancer and how many have died from treatment.

not on the radar of this American super visory authority, which is half financed by the pharmaceutical industry, because as a scientist he does not treat pati ents. He has been researching cancer since the 1990s and has experimentally found an approach that contradicts the “valid” genetic theory of carcinogenesis: Cancer is a disease of energy metabolism . Toxic medication therefore has no place in the therapy; only a (ketogenic) diet combined with (hyperbaric) oxygen the rapy can make sense. The successes in clinical studies are remarkable, but in the tsunami of pharma-financed “bre akthroughs” they hardly receive any attention. It goes without saying that the Wikipedia entry on Tom Seyfried only mentions his military career... Since Rockefeller's entry into the scene, acade mic medicine has been firmly in the grip of Big Pharma. The Covid crisis has cle arly documented this. This is also proven by Big Pharma's biggest business after Covid Pharma: the cancer business. It's about turnover and profit, not about our health.

Amazon no longer wanted to sell Dr. Paul Marik's book, but due to external pres sure, the sale started again. Paul Marik's book Cancer Care made this alternative cancer treatment known to a wide audience. Paul Marik is not just anyone: he is one of the world's most cited inten sive care physicians. He revolutionized the treatment of sep sis with high-dose vitamin C infusions and reduced mor tality by more than 50 percent. He revolutionized the early treatment of Covid-19 with repurposed drugs and reduced mortality by more than 90 percent. That was bold heresy— it was not allowed. Only vaccination was allowed to work against Covid-19. Paul Marik lost his license to practice. But Marik did not allow himself to be belittled. He used his newfound “free time” and analyzed thousands of stu dies on repurposed drugs in the treatment of cancer. The result, Cancer Care, is the standard work on alterna tive cancer therapy. The book soon became a bestseller. Where do we stand today? Of course, we know that radiation can cause cancer, probably because it cau ses massive damage to genetic material—not in one cell, but in millions of cells simultaneously. We also know that certain chemicals cause cancer; aniline and asbestos cancer have been recognized occupational cancers since the 1930s. Here too, it is not one cell or one mutation that causes the disease, but millions of chronically damaged cells.

Strong and Vital, No. 5

11